Literature DB >> 17597147

Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model.

Wim Anné1, Rik Willems, Patricia Holemans, Frank Beckers, Tania Roskams, Ilse Lenaerts, Hugo Ector, Hein Heidbüchel.   

Abstract

The development of atrial fibrillation (AF) is associated with electrical and structural remodeling. The aim of this study was to assess the contribution of electrical and structural remodeling to the development of AF in a rapid atrially paced ovine model with and without His bundle ablation and to determine the role of the angiotensin pathway and matrix metalloproteinases in this process. Thirty-five sheep were rapidly paced in the atrium and were randomized to undergo His bundle ablation (HBA) (21 sheep; HBA sheep) or not (14 sheep; non-HBA sheep). After HBA the ventricles were paced at 80 bpm. Both groups were subdivided to receive active treatment (quinapril+losartan) or placebo. Sheep were followed for 15 weeks. Inducible AF was defined as a rapid irregular atrial rhythm lasting >1 min. Inducible AF was considered to be persistent if during further follow-up no sinus rhythm (SR) was documented anymore. The inducibility of AF with atrial tachypacing was not different between the 4 groups. On the other hand, non-HBA sheep developed persistent AF significantly earlier than HBA sheep (p=0.028). They had elevated ventricular rates, diminished atrial MMP-2, increased TIMP-2 expression, and more extensive atrial fibrosis. Active treatment in these sheep significantly lowered AT-II (p=0.018), prevented atrial fibrogenesis (p<0.001) and slowed the development of persistent AF (p=0.049). Electrical remodeling is sufficient to induce AF, while structural changes are needed for persistent AF. Fibrosis development in our model is the result of an increased expression of AT-II in combination with changes in MMP expression. Inhibition of the angiotensin pathway suppresses atrial fibrosis and the development of persistent AF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597147     DOI: 10.1016/j.yjmcc.2007.05.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  31 in total

1.  A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Fumito Miyoshi; Hui-Ling Li; Norikazu Watanabe; Taku Asano; Kaoru Tanno; Jumpei Suyama; Atsuo Namiki; Takehiko Gokan; Youichi Kobayashi
Journal:  J Interv Card Electrophysiol       Date:  2013-09-13       Impact factor: 1.900

Review 2.  [Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].

Authors:  David Filgueiras-Rama; Sergio Castrejón; Conrado Calvo; Alejandro Estrada; David Doiny; Marta Ortega; Omer Berenfeld; José L Merino; José Jalife
Journal:  Arch Cardiol Mex       Date:  2012 Apr-Jun

Review 3.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

4.  Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium.

Authors:  David Filgueiras-Rama; Nicholas F Price; Raphael P Martins; Masatoshi Yamazaki; Uma Mahesh R Avula; Kuljeet Kaur; Jérôme Kalifa; Steven R Ennis; Elliot Hwang; Vijay Devabhaktuni; Jose Jalife; Omer Berenfeld
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-10-10

Review 5.  Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately.

Authors:  Paloma G Piña; Alexandru B Chicos
Journal:  Curr Atheroscler Rep       Date:  2017-01       Impact factor: 5.113

6.  Kinetics of atrial repolarization alternans in a free-behaving ovine model.

Authors:  Florian Jousset; Joanna Tenkorang; Jean-Marc Vesin; Patrizio Pascale; Patrick Ruchat; Anne Garderes Rollin; Martin Fromer; Sanjiv M Narayan; Etienne Pruvot
Journal:  J Cardiovasc Electrophysiol       Date:  2012-05-03

7.  Epicardial neural ganglionated plexus of ovine heart: anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery.

Authors:  Inga Saburkina; Kristina Rysevaite; Neringa Pauziene; Karl Mischke; Patrick Schauerte; José Jalife; Dainius H Pauza
Journal:  Heart Rhythm       Date:  2010-03-01       Impact factor: 6.343

Review 8.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

9.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

Review 10.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.